Allergy Therapeutics plc (AIM:AGY)
London · Delayed Price · Currency is GBP · Price in GBX 8.45
+0.20 (2.42%)
Oct 10, 2025, 4:35 PM GMT+1
Allergy Therapeutics Market Cap
Allergy Therapeutics has a market cap or net worth of 402.76 million as of October 10, 2025. Its market cap has increased by 79.79% in one year.
Market Cap
402.76M
Enterprise Value
425.61M
Revenue
55.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.45
Market Cap Chart
Since October 11, 2004, Allergy Therapeutics's market cap has increased from 30.57M to 402.76M, an increase of 1,217.54%. That is a compound annual growth rate of 13.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 402.76M | 30.00% |
| Dec 31, 2024 | 309.82M | 160.00% |
| Dec 29, 2023 | 119.16M | 180.75% |
| Dec 30, 2022 | 42.44M | -79.49% |
| Dec 31, 2021 | 206.98M | 94.57% |
| Dec 31, 2020 | 106.38M | 63.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 198.21B |
| GSK plc | 65.38B |
| Haleon | 30.16B |
| Smith & Nephew | 11.23B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 4.02B |
| HUTCHMED (China) | 1.99B |
| Genus | 1.68B |